The Rho-kinase pathway regulates angiotensin II-induced renal damage

Ruiz-Ortega, 2001, Proinflammatory actions of Angiotensin II, Curr Opin Nephrol Hypertens, 10, 321, 10.1097/00041552-200105000-00005 Mezzano, 2001, Angiotensin II and renal fibrosis, Hypertension, 38, 635, 10.1161/hy09t1.094234 Andersen, 2000, Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy, Kidney Int, 57, 601, 10.1046/j.1523-1755.2000.00880.x Ruiz-Ortega, 2003, Molecular mechanisms of angiotensin II-induced vascular injury, Curr Hypertens Rep, 5, 73, 10.1007/s11906-003-0014-0 Johnson, 1994, Renal injury from angiotensin II-mediated hypertension, Hypertension, 19, 464, 10.1161/01.HYP.19.5.464 Wolf, 1997, Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the Angiotensin type 2 receptor, J Clin Invest, 100, 1047, 10.1172/JCI119615 Ruiz-Ortega, 2001, Systemic infusion of angiotensin II into normal rats activates nuclear factor k-B and AP-1 in the kidney. Role of AT1 and AT2 receptors, Am J Pathol, 158, 1743, 10.1016/S0002-9440(10)64130-2 Ruiz-Ortega, 2002, Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney, Kidney Int, 82, 12, 10.1046/j.1523-1755.62.s82.4.x Ruperez, 2003, Angiotensin II increases connective tissue growth factor in the kidney, Am J Pathol, 163, 1937, 10.1016/S0002-9440(10)63552-3 Ruperez, 2003, The connective tissue growth factor is a mediator of angiotensin II-induced fibrosis, Circulation, 108, 1499, 10.1161/01.CIR.0000089129.51288.BA Yamakawa, 2000, Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells, Hypertension, 35, 313, 10.1161/01.HYP.35.1.313 Matrougui, 2001, Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries, Arterioscler Thromb Vasc Biol, 21, 1288, 10.1161/hq0801.093653 Takeda, 2001, Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression, Arterioscler Thromb Vasc Biol, 21, 868, 10.1161/01.ATV.21.5.868 Funakoshi, 2000, Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells, Hypertension, 38, 100, 10.1161/01.HYP.38.1.100 Aoki, 1998, Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation, Circ Res, 82, 666, 10.1161/01.RES.82.6.666 Bar-Sagi, 2000, Ras and Rho GTPases: A family reunion, Cell, 103, 227, 10.1016/S0092-8674(00)00115-X Kaibuchi, 1999, Regulation of cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells, Annu Rev Biochem, 68, 459, 10.1146/annurev.biochem.68.1.459 Amano, 1997, Formation of actin stress fiber and focal adhesions enhanced by Rho-kinase, Science, 275, 1308, 10.1126/science.275.5304.1308 Fukata, 1999, Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility, J Cell Biol, 145, 347, 10.1083/jcb.145.2.347 Kureishi, 1997, Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation, J Biol Chem, 272, 12257, 10.1074/jbc.272.19.12257 Yasui, 1998, Roles of Rho-associated kinase in cytokinesis; mutations in Rho-associated kinase phosphorylation sites impair cytokinetic segregation of glial filaments, J Cell Biol, 143, 1249, 10.1083/jcb.143.5.1249 Mukai, 2001, Involvement of Rho-kinase in hypertensive vascular disease: A novel therapeutic target in hypertension, FASEB J, 15, 1062 Heusinger-Ribeiro, 2001, Expression of connective tissue growth factor in human renal fibroblasts: Regulatory roles of RhoA and cAMP, J Am Soc Nephrol, 12, 1851, 10.1681/ASN.V1291853 Nagatoya, 2002, Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction, Kidney Int, 61, 1684, 10.1046/j.1523-1755.2002.00328.x Aznar, 2001, Searching new targets for anticancer drug design: The families of Ras and Rho GTPases and their effectors, Prog Nucleic Acid Res Mol Biol, 67, 193, 10.1016/S0079-6603(01)67029-6 Fu, 2001, Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3, J Biol Chem, 276, 45888, 10.1074/jbc.M105490200 Ishizaki, 2000, Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases, Mol Pharmacol, 57, 976 Ruiz-Ortega, 1998, Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 gene expression, J Immunol, 161, 430, 10.4049/jimmunol.161.1.430 Guijarro, 2001, Transcription factor κB (NF-κB) in renal disease, Kidney Int, 59, 415, 10.1046/j.1523-1755.2001.059002415.x Montaner, 1998, Multiple signalling pathways lead to the activation of the nuclear factor ?B by the Rho family of GTPases, J Biol Chem, 273, 12779, 10.1074/jbc.273.21.12779 Kanda, 2003, Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats, Kidney Int, 64, 2009, 10.1046/j.1523-1755.2003.00300.x Satoh, 2002, Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction, Eur J Pharmacol, 455, 169, 10.1016/S0014-2999(02)02619-5 Teraishi, 2004, Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats, Eur J Pharmacol, 505, 205, 10.1016/j.ejphar.2004.10.040 Nishikimi, 2004, Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats, Hypertens, 22, 1787, 10.1097/00004872-200409000-00024 Kataoka, 2002, Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats, Hypertension, 39, 245, 10.1161/hy0202.103271 Perbal, 2004, CCN proteins: Multifunctional signalling regulators, Lancet, 363, 62, 10.1016/S0140-6736(03)15172-0 Gupta, 2000, Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis, Kidney Int, 58, 1389, 10.1046/j.1523-1755.2000.00301.x Uehata, 1997, Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension, Nature, 389, 990, 10.1038/40187 Seko, 2003, Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle, Circ Res, 92, 411, 10.1161/01.RES.0000059987.90200.44